Vipin K. Garg
Directeur Général chez ALTIMMUNE, INC.
Fortune : 2 M $ au 30/06/2024
Provenance du réseau au premier degré de Vipin K. Garg
Entité | Type d'entité | Industrie | |
---|---|---|---|
University of Adelaide
34
| College/University | Other Consumer Services | 34 |
Subsidiary | Pharmaceuticals: Major | 22 | |
Public Company | Biotechnology | 22 | |
Subsidiary | Pharmaceuticals: Major | 13 | |
Bio Response, Inc.
Bio Response, Inc. Miscellaneous Commercial ServicesCommercial Services Bio Response, Inc. provides marketing and distribution services. The private company is based in Brooklyn, NY and has subsidiaries in the United States.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Indian Agricultural Research Institute
1
| College/University | Other Consumer Services | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Vipin K. Garg via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
CACI INTERNATIONAL INC | Information Technology Services | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Temasek Holdings Pte Ltd. (Investment Management)
Temasek Holdings Pte Ltd. (Investment Management) Financial ConglomeratesFinance Temasek Holdings Pte Ltd. (Investment Management) (Temasek-IM) is the investment management division of State-owned Temasek Holdings Pte Ltd., an investment holding company headquartered in Singapore. The firm was founded in 1974 to own and manage stakes previously held by the government of Singapore. Temasek-IM takes stakes in companies based in Singapore, Asia, and OECD countries, managing a portfolio of interests in TLCs (Temasek-Linked Companies). The firm also manages their own capital resources through a range of financial instruments. Some of their capital is managed by a third-party firm. | Financial Conglomerates | Investment Committee Member Investment Committee Member Investment Committee Member | |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
DiObex, Inc.
DiObex, Inc. Pharmaceuticals: MajorHealth Technology DiObex, Inc. develops therapies for metabolic disease treatment. Its products address the markets for the treatment of diabetes and its co-morbidities such as hypertension, dyslipidemia, and visceral adiposity. The company was founded in 2003 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
TENGION, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Theraclone Sciences, Inc.
Theraclone Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Theraclone Sciences, Inc. develops novel therapeutic antibodies for the treatment of cancer and infectious diseases. The firm leverages its proprietary antibody discovery technology, I-STARTM to identify rare fully human antibodies from immunologically relevant human subjects. The firm’s primary research focus is to discover novel targets and antibodies, and develop therapeutic monoclonal antibodies, by using its proprietary B-cell technology platform to mine the immune system of cancer patients. The company was founded by Johnny T. Stine in November 2004 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
NovaCardia, Inc.
NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
OREXIGEN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
TETRALOGIC PHARMACEUTICALS CORPORATION | Pharmaceuticals: Major | Founder Director/Board Member | |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | President President | |
National University of Singapore | College/University | Masters Business Admin Graduate Degree Graduate Degree | |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Pharmaceuticals: Major | Sales & Marketing Chief Tech/Sci/R&D Officer | |
The Biotechnology Greenhouse Corp. of Southeastern PA
The Biotechnology Greenhouse Corp. of Southeastern PA Investment ManagersFinance The Biotechnology Greenhouse Corp. of Southeastern PA (BioAdvance) is a venture capital firm founded in 2002. The firm is headquartered in Philadelphia, Pennsylvania. | Investment Managers | Corporate Officer/Principal Director/Board Member | |
The University of Texas at Austin | College/University | Masters Business Admin Graduate Degree | |
The Pennsylvania State University | College/University | Director/Board Member Masters Business Admin Undergraduate Degree | |
University of California, Irvine | College/University | Corporate Officer/Principal Undergraduate Degree | |
The University of California, San Francisco | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
Ascenta Therapeutics, Inc.
Ascenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascenta Therapeutics, Inc. engages in the discovery and development of medicines for cancer. Its core technology consists of agents designed to re-establish the natural program of apoptosis (cell death) in abnormal cancer cells. Its has three small molecule programs against distinct apoptosis targets: Bcl-2 (AT-101 – an oral pan-Bcl2 inhibitor), IAP (AT-406 – an oral multi-IAP inhibitor) and HDM2. The company was founded by Dajun Yang, Marc E. Lippman, and Shaomeng Wang on June 5, 2006 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
The University of Western Australia | College/University | Graduate Degree Doctorate Degree | |
Ben Franklin Technology Partners /Ventures/
Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Investment Managers | Director/Board Member Corporate Officer/Principal | |
Australasian Institute of Mining & Metallurgy
Australasian Institute of Mining & Metallurgy Miscellaneous Commercial ServicesCommercial Services Australasian Institute of Mining & Metallurgy, also known as AusIMM, is the leading organization for professionals working in the resources sector. AusIMM is based in Carlton, Australia, and has subsidiaries in Hong Kong. The Australian company's main focus is on shaping careers, showcasing leadership, creating communities, and upholding standards. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Life Technologies Corp.
Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal President | |
Tranzyme Pharma, Inc. (Canada) | Chairman Director/Board Member Director of Finance/CFO Chairman Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | ||
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Wellstat Biologics Corp.
Wellstat Biologics Corp. Pharmaceuticals: MajorHealth Technology Wellstat Biologics Corp. is a private company that focuses on the development and commercialization of biological agents. The company is based in Gaithersburg, MD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
XERIS BIOPHARMA HOLDINGS, INC. | Biotechnology | Director/Board Member Chief Executive Officer General Counsel Director/Board Member | |
NIOX GROUP PLC | Medical/Nursing Services | Director/Board Member Corporate Officer/Principal | |
3G Advisors LLC | Corporate Officer/Principal Corporate Officer/Principal | ||
ITERUM THERAPEUTICS PLC | Pharmaceuticals: Major | Chairman Director/Board Member | |
JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
Intrepida Bio, Inc.
Intrepida Bio, Inc. Pharmaceuticals: MajorHealth Technology Intrepida Bio, Inc. discovers and develops medicines to modulate the innate immune system to fight cancer and other diseases. The company was founded by Joel F. Martin and Olivier Laurent and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
The Johns Hopkins University School of Medicine | College/University | Graduate Degree Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 40 |
Australie | 4 |
Singapour | 3 |
Irlande | 3 |
Canada | 2 |
Sectorielle
Health Technology | 25 |
Consumer Services | 9 |
Finance | 5 |
Commercial Services | 5 |
Health Services | 3 |
Opérationnelle
Director/Board Member | 520 |
Corporate Officer/Principal | 233 |
Independent Dir/Board Member | 162 |
Chairman | 87 |
Chief Executive Officer | 87 |
Relations les plus connectées
Insiders | |
---|---|
Kok Kim Phua | 59 |
Nina Kjellson | 49 |
Michael Powell | 48 |
Eckard Weber | 46 |
John Johnson | 40 |
David Bartholomew | 32 |
Karen Smith | 30 |
Brenda D. Gavin | 29 |
Catherine Sohn | 27 |
Paul Edick | 27 |
George Abercrombie | 26 |
Shahul Hamid bin Mohd Ismail | 24 |
David Drutz | 24 |
John Schmid | 24 |
Caley Castelein | 23 |
- Bourse
- Insiders
- Vipin K. Garg
- Connexions Sociétés